{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:54:39Z","timestamp":1793055279750,"version":"4.5.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jpha.2025.101492","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T03:23:22Z","timestamp":1762572202000},"page":"101492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunocyte senescence: A new perspective on the remodeling of the ovarian cancer microenvironment and therapeutic intervention"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8811-2717","authenticated-orcid":false,"given":"Xiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8129-3812","authenticated-orcid":false,"given":"Xian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingnan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2025.101492_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.692360","article-title":"Shaping immune responses in the tumor microenvironment of ovarian cancer","volume":"12","author":"Luo","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.754069","article-title":"Senescence and immunoregulation in the tumor microenvironment","volume":"9","author":"Ruhland","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jpha.2025.101492_bib3","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41417-025-00947-z","article-title":"Integrated spatial transcriptome and metabolism study reveals metabolic heterogeneity in human bladder cancer","volume":"32","author":"Lu","year":"2025","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jpha.2025.101492_bib4","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/s42255-020-00305-3","article-title":"Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages","volume":"2","author":"Covarrubias","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.jpha.2025.101492_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semcancer.2020.11.021","article-title":"Where does cellular senescence belong in the pathophysiology of ovarian cancer?","volume":"81","author":"Ksi\u0105\u017cek","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jpha.2025.101492_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/cells12030352","article-title":"Proteoglycan SPOCK1 as a poor prognostic marker promotes malignant progression of clear cell renal cell carcinoma via triggering the snail\/slug-MMP-2 axis-mediated epithelial-to-mesenchymal transition","volume":"12","author":"Lin","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jpha.2025.101492_bib7","article-title":"Modeling of senescence-related chemoresistance in ovarian cancer using data analysis and patient-derived organoids","volume":"13","author":"Cai","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jpha.2025.101492_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/acel.70209","article-title":"Single-cell fluorescence imaging reveals heterogeneity in senescence biomarkers and identifies rapamycin-responsive sub-populations","volume":"24","author":"Seshadri","year":"2025","journal-title":"Aging Cell"},{"key":"10.1016\/j.jpha.2025.101492_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1631\/jzus.B2200178","article-title":"Multiple characteristic alterations and available therapeutic strategies of cellular senescence","volume":"24","author":"Zhao","year":"2023","journal-title":"J. Zhejiang Univ. - Sci. B"},{"key":"10.1016\/j.jpha.2025.101492_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911082","article-title":"Senescence of tumor cells in anticancer therapy-beneficial and detrimental effects","volume":"23","author":"Piskorz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101492_bib11","doi-asserted-by":"crossref","first-page":"7956","DOI":"10.3390\/ijms24097956","article-title":"Immunosenescence and skin: a state of art of its etiopathogenetic role and crucial watershed for systemic implications","volume":"24","author":"Papa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101492_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13045-020-00986-z","article-title":"Immunosenescence: a key player in cancer development","volume":"13","author":"Lian","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jpha.2025.101492_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036045","article-title":"Immunosenescence and cancer: opportunities and challenges","volume":"102","author":"Fu","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.jpha.2025.101492_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1265525","article-title":"Metabolic and senescence characteristics associated with the immune microenvironment in ovarian cancer","volume":"14","author":"Xiong","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jpha.2025.101492_bib15","first-page":"1","article-title":"T cell exhaustion and senescence for ovarian cancer immunotherapy","volume":"104\u2013105","author":"Zhao","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jpha.2025.101492_bib16","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.3390\/cancers15245835","article-title":"Implications of senescent T cells for cancer immunotherapy","volume":"15","author":"Kasamatsu","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101492_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12979-020-0173-8","article-title":"Contributions of age-related thymic involution to immunosenescence and inflammaging","volume":"17","author":"Thomas","year":"2020","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.jpha.2025.101492_bib18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.coi.2012.12.003","article-title":"T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment","volume":"25","author":"Crespo","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41423-019-0344-8","article-title":"Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment, cell","volume":"17","author":"Zhao","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib20","article-title":"Differential regulation of calcium-NFAT signaling pathway by Akt isoforms: unraveling effector dynamics and exhaustion of cytotoxic T lymphocytes in tumor microenvironment","volume":"13","author":"Chen","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jpha.2025.101492_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41388-020-01501-x","article-title":"Counteracting CAR T cell dysfunction","volume":"40","author":"Poorebrahim","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.jpha.2025.101492_bib22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jpha.2025.101492_bib23","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3389\/fimmu.2018.02569","article-title":"T-cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune responses","volume":"9","author":"Saeidi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41577-020-00454-2","article-title":"Rethinking peripheral T cell tolerance: checkpoints across a T cell\u2019s journey","volume":"21","author":"ElTanbouly","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2017.12.004","article-title":"The tumor microenvironment: thousand obstacles for effector T cells","volume":"343","author":"Massa","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","article-title":"Aging and aging-related diseases: from molecular mechanisms to interventions and treatments","volume":"7","author":"Guo","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jpha.2025.101492_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41590-022-01398-6","article-title":"YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells","volume":"24","author":"Ma","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib28","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3390\/ijms18081742","article-title":"Markers of T cell senescence in humans","volume":"18","author":"Xu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101492_bib29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41392-025-02269-w","article-title":"CAR-T cell therapy for cancer: current challenges and future directions","volume":"10","author":"Zugasti","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jpha.2025.101492_bib30","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.3390\/jcm12144780","article-title":"Polymorphisms of killer ig-like receptors and the risk of glioblastoma","volume":"12","author":"Choi","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jpha.2025.101492_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41392-020-00348-8","article-title":"Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy","volume":"5","author":"Cao","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jpha.2025.101492_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.683381","article-title":"Optimizing NK cell-based immunotherapy in myeloid leukemia: abrogating an immunosuppressive microenvironment","volume":"12","author":"Kaweme","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib33","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.3390\/cancers12123504","article-title":"Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes","volume":"12","author":"Pesce","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101492_bib34","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3389\/fimmu.2019.01850","article-title":"A natural impact: NK cells at the intersection of cancer and HIV disease","volume":"10","author":"Lucar","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib35","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.3390\/cancers12113301","article-title":"Immune checkpoint blockade in gynecologic cancers: state of affairs","volume":"12","author":"Drakes","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101492_bib36","doi-asserted-by":"crossref","DOI":"10.4110\/in.2019.19.e37","article-title":"Aging and the immune system: the impact of immunosenescence on viral infection, immunity and vaccine immunogenicity","volume":"19","author":"Oh","year":"2019","journal-title":"Immune Netw."},{"key":"10.1016\/j.jpha.2025.101492_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2021.748591","article-title":"Patho-physiology of aging and immune-senescence: possible correlates with comorbidity and mortality in middle-aged and old COVID-19 patients","volume":"2","author":"Farheen","year":"2021","journal-title":"Front. Aging"},{"key":"10.1016\/j.jpha.2025.101492_bib38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13048-023-01300-4","article-title":"The stromal microenvironment and ovarian aging: mechanisms and therapeutic opportunities","volume":"16","author":"Shen","year":"2023","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.jpha.2025.101492_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101917","article-title":"High-dimensional deconstruction of ovarian cancer at single-cell precision reveals HEBP2 that reshape the TIME and drive carboplatin resistance","volume":"44","author":"Yang","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jpha.2025.101492_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004029","article-title":"CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype","volume":"10","author":"Li","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jpha.2025.101492_bib41","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1038\/s41598-024-53854-y","article-title":"HIF-2\u03b1-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K\/Akt pathway to inhibit apoptosis and facilitate DNA repair process","volume":"14","author":"Ma","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2025.101492_bib42","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.3390\/cancers14215224","article-title":"Metabolic reprogramming in tumor-associated macrophages in the ovarian tumor microenvironment","volume":"14","author":"Kumar","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101492_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-020-00251-y","article-title":"Metabolic reprogramming in macrophage responses","volume":"9","author":"Liu","year":"2021","journal-title":"Biomark. Res."},{"key":"10.1016\/j.jpha.2025.101492_bib44","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/jbm.a.37391","article-title":"Supramolecular nanotherapeutics enable metabolic reprogramming of tumor-associated macrophages to inhibit tumor growth","volume":"110","author":"Ramesh","year":"2022","journal-title":"J. Biomed. Mater. Res., Part A"},{"key":"10.1016\/j.jpha.2025.101492_bib47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.it.2009.05.004","article-title":"Human innate immunosenescence: causes and consequences for immunity in old age","volume":"30","author":"Panda","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib48","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1007\/s00784-023-05297-4","article-title":"Comparison of immunoexpression of dendritic cells, mast cells and blood vessels in periodontal disease between adults and elderly","volume":"27","author":"de Vasconcelos Gurgel","year":"2023","journal-title":"Clin. Oral Investig."},{"key":"10.1016\/j.jpha.2025.101492_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.595369","article-title":"Lipopolysaccharide-activated bone marrow-derived dendritic cells suppress allergic airway inflammation by ameliorating the immune microenvironment","volume":"12","author":"Min","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib50","first-page":"2518","article-title":"Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response","volume":"184","author":"Qian","year":"2010","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.jpha.2025.101492_bib51","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2290643","article-title":"The impact of aging-induced gut microbiome dysbiosis on dendritic cells and lung diseases","volume":"15","author":"Malik","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jpha.2025.101492_bib52","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.immuni.2023.10.013","article-title":"Single-cell atlas of healthy human blood unveils age-related loss of NKG2C+GZMB\u2013CD8+ memory T cells and accumulation of type 2 memory T cells","volume":"56","author":"Terekhova","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jpha.2025.101492_bib53","first-page":"1138","article-title":"Increased reactivity of dendritic cells from aged subjects to self-antigen, the human DNA","volume":"182","author":"Agrawal","year":"2009","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.jpha.2025.101492_bib54","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10522-018-9771-7","article-title":"Reversing the immune ageing clock: Lifestyle modifications and pharmacological interventions","volume":"19","author":"Duggal","year":"2018","journal-title":"Biogerontology"},{"issue":"Suppl 18","key":"10.1016\/j.jpha.2025.101492_bib55","first-page":"S153","article-title":"Age-related changes in immune function (immune senescence) in caries and periodontal diseases: a systematic review","volume":"44","author":"Preshaw","year":"2017","journal-title":"J. Clin. Periodontology"},{"key":"10.1016\/j.jpha.2025.101492_bib56","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.3390\/cancers13246231","article-title":"Barriers to immunotherapy in ovarian cancer: Metabolic, genomic, and immune perturbations in the tumour microenvironment","volume":"13","author":"Johnson","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101492_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114963","article-title":"Reshaping immunometabolism in the tumour microenvironment to improve cancer immunotherapy","volume":"164","author":"Chen","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jpha.2025.101492_bib58","first-page":"39","article-title":"Unlocking the potential of immunotherapy in platinum-resistant ovarian cancer: rationale, challenges, and novel strategies, cancer drug resist","volume":"7","author":"Kefas","year":"2024","journal-title":"Alhambra Calif"},{"key":"10.1016\/j.jpha.2025.101492_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104216","article-title":"Obstacles for T-lymphocytes in the tumour microenvironment: therapeutic challenges, advances and opportunities beyond immune checkpoint","volume":"83","author":"Verma","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jpha.2025.101492_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.795547","article-title":"Immunotherapy in ovarian cancer: thinking beyond PD-1\/PD-L1","volume":"11","author":"Chardin","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jpha.2025.101492_bib61","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3390\/cancers13050963","article-title":"Mouse models of peritoneal carcinomatosis to develop clinical applications","volume":"13","author":"Bella","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101492_bib62","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cellimm.2012.06.014","article-title":"Anti-tumor immunity: myeloid leukocytes control the immune landscape","volume":"278","author":"Rutkowski","year":"2012","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1017120","article-title":"A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy","volume":"13","author":"Pan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib64","article-title":"Depletion of regulatory T lymphocytes reverses the imbalance between pro- and anti-tumor immunities via enhancing antigen-specific T cell immune responses","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jpha.2025.101492_bib65","article-title":"Potential role of phytochemicals against matrix metalloproteinase induced breast cancer; an explanatory review","volume":"8","author":"Khan","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.jpha.2025.101492_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207255","article-title":"MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors","volume":"13","author":"Juric","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jpha.2025.101492_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000312","article-title":"LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity","volume":"2","author":"Tester","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.jpha.2025.101492_bib68","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.biopha.2018.05.155","article-title":"Matrix metalloproteinase-2: a key regulator in coagulation proteases mediated human breast cancer progression through autocrine signaling","volume":"105","author":"Das","year":"2018","journal-title":"Biomedecine Pharmacother"},{"key":"10.1016\/j.jpha.2025.101492_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1064033","article-title":"Immunomodulatory role of metalloproteases in cancers: current progress and future trends","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib70","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.2174\/13816128113196660701","article-title":"Metalloproteinases and metalloproteinase inhibitors in age-related diseases","volume":"20","author":"Gargiulo","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpha.2025.101492_bib71","first-page":"905","article-title":"Enterolactone suppresses proliferation, migration and metastasis of MDA-MB-231 breast cancer cells through inhibition of uPA induced plasmin activation and MMPs-Mediated ECM remodeling","volume":"18","author":"Mali","year":"2017","journal-title":"Asian. Pac. J. Cancer. Prev."},{"key":"10.1016\/j.jpha.2025.101492_bib72","article-title":"High-grade serous ovarian cancer development and anti-PD-1 resistance is driven by IRE1\u03b1 activity in neutrophils","author":"Emmanuelli","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.jpha.2025.101492_bib73","first-page":"842","article-title":"Next generation sequencing and molecular biomarkers in ovarian cancer-an opportunity for targeted therapy","volume":"12","author":"Harbin","year":"2022","journal-title":"Diagn. Basel Switz."},{"key":"10.1016\/j.jpha.2025.101492_bib74","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.6004\/jnccn.2016.0123","article-title":"Next-generation sequencing: role in gynecologic cancers","volume":"14","author":"Evans","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.jpha.2025.101492_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277285","article-title":"Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells","volume":"18","author":"Jang","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jpha.2025.101492_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113978","article-title":"Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10\/STAT3\/PD-L1 signaling pathways","volume":"274","author":"Deng","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jpha.2025.101492_bib77","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1038\/s41598-021-81973-3","article-title":"Changes in telomere length and senescence markers during human ovarian tissue cryopreservation","volume":"11","author":"Kim","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2025.101492_bib78","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/cancers12020296","article-title":"Deciphering the molecular mechanism of spontaneous senescence in primary epithelial ovarian cancer cells","volume":"12","author":"Paku\u0142a","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101492_bib79","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1038\/emboj.2012.132","article-title":"Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions","volume":"31","author":"Suram","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.jpha.2025.101492_bib80","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s11658-021-00287-4","article-title":"Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro","volume":"26","author":"Uruski","year":"2021","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.jpha.2025.101492_bib81","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12943-018-0855-4","article-title":"Epigenetics in ovarian cancer: premise, properties, and perspectives","volume":"17","author":"Yang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jpha.2025.101492_bib82","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.3390\/genes12121856","article-title":"Nuclear sirtuins and the aging of the immune system","volume":"12","author":"G\u00e1mez-Garc\u00eda","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.jpha.2025.101492_bib83","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/bs.vh.2020.12.011","article-title":"Sirtuins and the prevention of immunosenescence","volume":"115","author":"Lasigli\u00e8","year":"2021","journal-title":"Vitam Horm"},{"key":"10.1016\/j.jpha.2025.101492_bib84","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/acel.12685","article-title":"Sirtuins at the crossroads of stemness, aging, and cancer","volume":"16","author":"O'Callaghan","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.jpha.2025.101492_bib85","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/ijms17050759","article-title":"A comparative analysis of genetic and epigenetic events of breast and ovarian cancer related to tumorigenesis","volume":"17","author":"Longacre","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101492_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111466","article-title":"The roles of H3K9me3 writers, readers, and erasers in cancer immunotherapy","volume":"25","author":"Oleksiewicz","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101492_bib87","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3389\/fimmu.2020.00619","article-title":"Histone deacetylase SIRT1 mediates C5b-9-induced cell cycle in oligodendrocytes","volume":"11","author":"Tatomir","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib88","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13048-022-01032-x","article-title":"The role of oxidative stress in ovarian aging: a review","volume":"15","author":"Yan","year":"2022","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.jpha.2025.101492_bib89","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12951-022-01566-8","article-title":"Biomaterials and advanced technologies for the evaluation and treatment of ovarian aging","volume":"20","author":"Wu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jpha.2025.101492_bib90","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.3390\/ijms24129828","article-title":"Metabolic mechanisms and potential therapeutic targets for prevention of ovarian aging: data from up-to-date experimental studies","volume":"24","author":"Valtetsiotis","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101492_bib91","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/s41416-023-02168-3","article-title":"The DNA damage response in advanced ovarian cancer: functional analysis combined with machine learning identifies signatures that correlate with chemotherapy sensitivity and patient outcome","volume":"128","author":"Walker","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jpha.2025.101492_bib92","article-title":"The role of oxidative stress and natural antioxidants in ovarian aging","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpha.2025.101492_bib93","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.18632\/oncotarget.1143","article-title":"Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype","volume":"4","author":"Ohanna","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpha.2025.101492_bib94","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/2159-8290.CD-16-0241","article-title":"Cellular senescence promotes adverse effects of chemotherapy and cancer relapse","volume":"7","author":"Demaria","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jpha.2025.101492_bib95","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.3390\/ijms24043436","article-title":"The potential of senescence as a target for developing anticancer therapy","volume":"24","author":"Jo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101492_bib96","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.7150\/jca.84930","article-title":"The roles of exosomes in ovarian cancer chemo-resistance","volume":"14","author":"Liu","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.jpha.2025.101492_bib97","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3390\/ijms22042165","article-title":"Exosomes as biomarkers for female reproductive diseases diagnosis and therapy","volume":"22","author":"Esfandyari","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101492_bib98","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41419-022-04510-8","article-title":"Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion","volume":"13","author":"Tian","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jpha.2025.101492_bib99","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3390\/cells11091483","article-title":"Immunosuppressive extracellular vesicles as a linking factor in the development of tumor and endometriotic lesions in the gynecologic tract","volume":"11","author":"Soroczynska","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jpha.2025.101492_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315182","article-title":"The relationship between reactive oxygen species and the cGAS\/STING signaling pathway in the inflammaging process","volume":"23","author":"Andrade","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101492_bib101","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s12272-014-0474-6","article-title":"Age-related inflammation and insulin resistance: a review of their intricate interdependency","volume":"37","author":"Park","year":"2014","journal-title":"Arch. Pharmacal Res."},{"key":"10.1016\/j.jpha.2025.101492_bib102","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3390\/cells10081906","article-title":"Role of NF-\u03baB in ageing and age-related diseases: lessons from genetically modified mouse models","volume":"10","author":"Garc\u00eda-Garc\u00eda","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jpha.2025.101492_bib103","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","article-title":"cGAS\u2013STING drives ageing-related inflammation and neurodegeneration","volume":"620","author":"Gulen","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2025.101492_bib104","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: signaling pathways and intervention therapies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jpha.2025.101492_bib105","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/cells13060550","article-title":"The molecular mechanisms in senescent cells induced by natural aging and ionizing radiation","volume":"13","author":"Ibragimova","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jpha.2025.101492_bib106","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/15384101.2024.2325802","article-title":"Sustained activation of NF-\u03baB through constitutively active IKK\u03b2 leads to senescence bypass in murine dermal fibroblasts","volume":"23","author":"Harada","year":"2024","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jpha.2025.101492_bib107","doi-asserted-by":"crossref","first-page":"321","DOI":"10.14336\/AD.2024.0219","article-title":"Senescent T cells in age-related diseases","volume":"16","author":"Yu","year":"2024","journal-title":"Aging Dis"},{"key":"10.1016\/j.jpha.2025.101492_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810692","article-title":"Immune tumor microenvironment in ovarian cancer ascites","volume":"23","author":"Almeida-Nunes","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101492_bib109","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2017.00024","article-title":"The unique molecular and cellular microenvironment of ovarian cancer","volume":"7","author":"Worzfeld","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jpha.2025.101492_bib110","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3389\/fchem.2020.00543","article-title":"Recent advances of gold compounds in anticancer immunity","volume":"8","author":"Yue","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.jpha.2025.101492_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.787897","article-title":"ARID1A downregulation predicts high PD-L1 expression and worse clinical outcome in patients with gallbladder cancer","volume":"12","author":"Nan","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jpha.2025.101492_bib112","article-title":"Ligand mobility modulates immunological synapse formation and T cell activation","volume":"7","author":"Hsu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jpha.2025.101492_bib113","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.celrep.2018.06.114","article-title":"F-actin-driven CD28-CD80 localization in the immune synapse","volume":"24","author":"Siokis","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jpha.2025.101492_bib114","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3389\/fimmu.2018.01174","article-title":"Sailing to and docking at the immune synapse: role of tubulin dynamics and molecular motors","volume":"9","author":"Mart\u00edn-C\u00f3freces","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib115","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/cells8080789","article-title":"A ciliary view of the immunological synapse","volume":"8","author":"Cassioli","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jpha.2025.101492_bib116","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.3390\/ijms21072475","article-title":"Various stages of immune synapse formation are differently dependent on the strength of the TCR stimulus","volume":"21","author":"Estl","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101492_bib117","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.0105-2896.2010.00904.x","article-title":"Cytotoxic immunological synapses","volume":"235","author":"Dustin","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jpha.2025.101492_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.670882","article-title":"F-actin dynamics in the regulation of endosomal recycling and immune synapse assembly","volume":"9","author":"Capitani","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jpha.2025.101492_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.0020171","article-title":"Geometrically repatterned immunological synapses uncover formation mechanisms","volume":"2","author":"Figge","year":"2006","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jpha.2025.101492_bib120","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1111\/jcmm.17802","article-title":"Adenosine receptor A2b confers ovarian cancer survival and PARP inhibitor resistance through IL-6-STAT3 signalling","volume":"27","author":"Chi","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.jpha.2025.101492_bib121","doi-asserted-by":"crossref","first-page":"39154","DOI":"10.18632\/oncotarget.16610","article-title":"IL-6R\/STAT3\/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpha.2025.101492_bib122","first-page":"2081","article-title":"CAFs enhance paclitaxel resistance by inducing EMT through the IL-6\/JAK2\/STAT3 pathway","volume":"39","author":"Wang","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jpha.2025.101492_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111180","article-title":"CXXC5 drove inflammation and ovarian cancer proliferation via transcriptional activation of ZNF143 and EGR1","volume":"119","author":"Geng","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jpha.2025.101492_bib124","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41389-019-0165-8","article-title":"The crosstalk between STAT3 and p53\/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug\/MAPK\/PI3K\/AKT-mediated regulation of EMT and autophagy","volume":"8","author":"Liang","year":"2019","journal-title":"Oncogenesis"},{"key":"10.1016\/j.jpha.2025.101492_bib125","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.3390\/cancers14143437","article-title":"A novel ALDH1A1 inhibitor blocks platinum-induced senescence and stemness in ovarian cancer","volume":"14","author":"Muralikrishnan","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101492_bib126","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/1535-7163.MCT-22-0396","article-title":"Bepotastine sensitizes ovarian cancer to PARP inhibitors through suppressing NF-\u03baB-triggered SASP in cancer-associated fibroblasts","volume":"22","author":"Jin","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jpha.2025.101492_bib127","article-title":"The implication of IL-6 in the invasiveness and chemoresistance of ovarian cancer cells. Systematic review of its potential role as a biomarker in ovarian cancer patients","volume":"1876","author":"Szulc-Kielbik","year":"2021","journal-title":"Biochim. Biophys. Acta BBA Rev. Cancer"},{"key":"10.1016\/j.jpha.2025.101492_bib128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12032-024-02328-2","article-title":"IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3\/HIF-1\u03b1 pathway","volume":"41","author":"Guo","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jpha.2025.101492_bib129","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.3390\/cancers16152676","article-title":"IFN\u03b3-induced Bcl3, PD-L1 and IL-8 signaling in ovarian cancer: mechanisms and clinical significance","volume":"16","author":"Reddy","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101492_bib130","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.3390\/cells11244026","article-title":"Therapy-induced stromal senescence promoting aggressiveness of prostate and ovarian cancer","volume":"11","author":"Pardella","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jpha.2025.101492_bib131","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2117754119","article-title":"Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer","volume":"119","author":"Paffenholz","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.jpha.2025.101492_bib132","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.3390\/cancers14184344","article-title":"Prognostic and predictive role of tumor-infiltrating lymphocytes (TILs) in ovarian cancer","volume":"14","author":"Fanale","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101492_bib133","first-page":"203","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer, N Engl J","volume":"348","author":"Zhang","year":"2003","journal-title":"Med"},{"key":"10.1016\/j.jpha.2025.101492_bib134","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.ajpath.2024.02.016","article-title":"A deep learning-based assessment pipeline for intraepithelial and stromal tumor-infiltrating lymphocytes in high-grade serous ovarian carcinoma","volume":"194","author":"Hamada","year":"2024","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jpha.2025.101492_bib135","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/biomedicines9040330","article-title":"Patient-specific variables determine the extent of cellular senescence biomarkers in ovarian tumors in vivo","volume":"9","author":"Uruski","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpha.2025.101492_bib136","first-page":"1025","article-title":"Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with erlotinib in patients with advanced solid tumors, Cancer Chemother","volume":"76","author":"Tolcher","year":"2015","journal-title":"Pharmacol."},{"key":"10.1016\/j.jpha.2025.101492_bib138","doi-asserted-by":"crossref","first-page":"9992","DOI":"10.3390\/ijms24129992","article-title":"In vitro and in vivo efficacy of a stroma-targeted, tumor microenvironment responsive oncolytic adenovirus in different preclinical models of cancer","volume":"24","author":"Alfano","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101492_bib139","article-title":"Efficacy evaluation of multi-immunotherapy in ovarian cancer: from bench to bed","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib140","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1200\/JCO.21.00306","article-title":"Atezolizumab, bevacizumab, and chemotherapy for newly diagnosed stage III or IV ovarian cancer: Placebo-controlled randomized phase III trial (IMagyn050\/GOG 3015\/ENGOT-OV39)","volume":"39","author":"Moore","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jpha.2025.101492_bib141","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S1470-2045(21)00342-9","article-title":"Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial","volume":"22","author":"Monk","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jpha.2025.101492_bib142","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S1470-2045(21)00216-3","article-title":"Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study","volume":"22","author":"Pujade-Lauraine","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jpha.2025.101492_bib143","doi-asserted-by":"crossref","first-page":"33783","DOI":"10.18632\/oncotarget.9277","article-title":"AMPK-dependent and independent effects of AICAR and compound C on T-cell responses","volume":"7","author":"Rao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpha.2025.101492_bib144","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.3390\/cancers12092586","article-title":"Synergistic anti-tumor activity by targeting multiple signaling pathways in ovarian cancer","volume":"12","author":"Wen","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101492_bib145","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/sj.bjc.6602933","article-title":"Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer","volume":"94","author":"le Page","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jpha.2025.101492_bib146","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1371\/journal.pmed.1000025","article-title":"Ovarian cancer: a clinical challenge that needs some basic answers","volume":"6","author":"Lawrenson","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.jpha.2025.101492_bib147","first-page":"4736","article-title":"Investigating the mechanisms of drug resistance and prognosis in ovarian cancer using single-cell RNA sequencing and bulk RNA sequencing","volume":"16","author":"Liu","year":"2024","journal-title":"Aging"},{"key":"10.1016\/j.jpha.2025.101492_bib148","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.3390\/cancers15225356","article-title":"New achievements from molecular biology and treatment options for refractory\/relapsed ovarian cancer-a systematic review","volume":"15","author":"Bachmann","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101492_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1489235","article-title":"Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy","volume":"15","author":"Gronauer","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101492_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119461","article-title":"Prognostic value of immune-related cells and genes in the tumor microenvironment of ovarian cancer, especially CST4","volume":"277","author":"Wang","year":"2021","journal-title":"Life Sci."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925003090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925003090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:33:06Z","timestamp":1784647986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177925003090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":147,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2095177925003090"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101492","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunocyte senescence: A new perspective on the remodeling of the ovarian cancer microenvironment and therapeutic intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"101492"}}